title: Do you approve of spending $300 million on HPV vaccination?: yes.
authors.affiliation: Institut national de santé publique du Québec, 190 Crémazie Blvd E, Montreal, QC. marc.steben@inspq.qc.ca
authors.forename: Marc
authors.initials: M
authors.lastname: Steben
mesh_terms: D052685:Alphapapillomavirus; D002170:Canada; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D005260:Female; D005102:Health Expenditures; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D030361:Papillomavirus Infections / Q000191:economics* / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics*
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines